CORRECTING and REPLACING -- INC Research Completes

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CORRECTING and REPLACING -- INC Research Completes Secondary Offering, Stock Repurchase and Debt Refinancing; Updates 2015 Business Outlook

RALEIGH, N.C., May 14, 2015 (GLOBE NEWSWIRE) -- In the press release issued earlier today by INC Research Holdings, Inc. (Nasdaq: INCR ) under the same headline, please note that the maturity date mentioned in the Senior Credit Facilities section should be May 14, 2020, not May 14, 2019 as previously stated. All other information remains the same. The full and corrected release follows:

INC Research Holdings, Inc. (Nasdaq: INCR ), a leading global Phase I to Phase IV contract research organization, today completed the previously announced secondary public offering of 8,050,000 shares of the Company's Class A common stock by its existing shareholders and the repurchase of 5,053,482 shares of its Class A common stock. In addition, the Company also announced the refinancing of its credit facility through entry into a new $675 million senior secured credit facility, or Senior Credit Facility, consisting of a $525 million term loan and a revolving credit facility of $150 million.

Share Repurchase

INC Research has completed the repurchase of 5,053,482 shares of its Class A common stock from affiliates of Avista Capital Partners, L.P. and affiliates of Teachers' Private Capital, the private investment arm of Ontario Teachers' Pension Plan Board, in a private transaction. The purchase price was approximately $150 million or $29.6825 per share, which is equal to the price paid by the underwriters to the selling shareholders in the secondary public offering. The Company funded the repurchase through $101.5 million of additional borrowings under its Senior Credit Facility, with the remainder coming from cash on hand.

Senior Credit Facilities

INC Research has entered into a $675 million senior secured credit agreement and related security and other agreements. The credit facilities established by these agreements consist of a $525 million term loan and a $150 million revolving credit facility with certain lenders and Wells Fargo Bank, National Association, as administrative agent and collateral agent.

Borrowings under the Senior Credit Facility bear interest at a rate per annum equal to an applicable margin plus the one-month LIBOR rate. The applicable margin for borrowings is initially 2.00%, with reductions subject to a pricing grid.

The Senior Credit Facilities require the Company to make scheduled quarterly payments of 5% of the original principal amount of the Senior Credit Facilities in year one, 7.5% in years two and three, 10% in year four, and 12.5% in year five, with the balance due on the maturity date of May 14, 2020.

Business Outlook Update

The Company is updating its 2015 full-year guidance as outlined in the following table to reflect the impact of the repurchase of 5,053,428 shares of its Class A common stock and the additional borrowings under its Senior Credit Facility noted above. The guidance previously issued by the Company on April 27, 2015 included the impact of the refinancing of its existing credit agreement and the resulting decreased interest cost but did not reflect the impact of the repurchase of its Class A common stock, namely the additional interest expense resulting from the increased debt balances and the increase in earnings per share resulting from the reduced number of shares outstanding.

  Revised Guidance Guidance Issued
  5/14/2015 4/27/2015
  Low High Low High
Net service revenue $880.0 million $905.0 million $880.0 million $905.0 million
Adjusted Net Income $87.5 million $95.0 million $89.5 million $97.0 million
GAAP diluted EPS $1.15 $1.31 $1.13 $1.29
Adjusted diluted EPS $1.45 $1.57 $1.40 $1.52

Important disclosures about and reconciliations of non-GAAP measures, adjusted net income and diluted adjusted earnings per share to the corresponding GAAP measures are provided below:

Reconciliation of GAAP to Non-GAAP Full-Year 2015 Guidance
(in millions, except per share data)
(unaudited)
         
    Adjusted Diluted
  Adjusted Net Income Earnings Per Share
  Low High Low High
Net income and diluted earnings per share $70.0 $79.5 $1.15 $1.31
Adjustments:        
Amortization(a) 37.7 37.7    
Stock-based compensation expense(a) 4.2 4.2    
Contingent consideration treated as compensation expense(a) 0.6 0.6    
Transaction expenses(a) 1.1 1.1    
Restructuring expenses(a) 2.6 2.6    
Asset impairment charges(a) 3.9 3.9    
Debt extinguishment costs(a) 9.9 9.9    
Other(a) (4.0) (3.5)    
Income tax effect of above adjustments(b) (38.5) (41.0)    
Adjusted net income and adjusted diluted earnings per share $87.5 $95.0 $1.45 $1.57
         
(a)  Amounts are estimates with an estimated range of +/- 5% and are presented gross without the benefit of income tax reduction.
         
(b)  Income tax expense is calculated and the adjustments are tax affected at an approximate rate of 36%, which is the midpoint of our range for the expected income tax rate of 35% to 37%. This adjustment also excludes the impact of the valuation allowances recorded against the Company's deferred tax assets. Historically, INC Research has recorded a valuation allowance against some of its deferred tax assets, but the Company believes that these valuation allowances cause significant fluctuations in its financial results that are not indicative of its underlying financial performance.

Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release, including our updated 2015 guidance, are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include, but are not limited to: fluctuations in our financial results; our ability to maintain or generate new business awards; our backlog not being indicative of future revenues and our ability to realize the anticipated future revenue reflected in our backlog; our ability to adequately price our contracts and not overrun cost estimates; our customer or therapeutic area concentration; international economic, political and other risks; our ability to increase our market share, grow our business and execute our growth strategies; and the other risk factors set forth in our Form 10-K for the year ended December 31, 2014, and other SEC filings, copies of which are available free of charge on our website at www.incresearch.com . INC Research assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Non-GAAP Measures

INC Research defines Adjusted Net Income (including Adjusted Diluted Earnings per Share) as net income (including Diluted Earnings per Share) excluding amortization, other income (expense) and the items excluded from adjusted income from operations mentioned previously. After giving effect to these items, we have also included an adjustment to our income tax rate to reflect the expected long-term income tax rate.

Each of the non-GAAP measures noted above are used by management and the Board to evaluate our core operating results as they exclude certain items whose fluctuations from period-to-period do not necessarily correspond to changes in the core operations of the business. Adjusted Net Income (including Adjusted Diluted Earnings per Share) is used by management and the Board to assess our business, as well as by investors and analysts, to measure our performance.

Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company's results of operations as determined in accordance with GAAP. Investors are encouraged to review the reconciliations of the non-GAAP financial measures to their most directly comparable GAAP measures included in this press release and the accompanying tables

About INC Research

INC Research (Nasdaq: INCR ) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was ranked "Top CRO to Work With" among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries. For more information, please visit http://www.incresearch.com .

Investor Relations Contact: Ronnie Speight Vice President, Investor Relations Phone: +1 (919) 745-2745 Email: Press/Media Contact: Lori Dorer Senior Director, Corporate Communications Phone: +1 (513) 345-1685 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 19

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 88

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 150

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 123

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Stitch AI Targets Banking’s Hardest Automation Gap

Updated Category News Views 15

The flashy chatbot stuff is cheap; banking permission to act is not. That is why Stitch AI’s launch deserves more attention than another vendor slapping “agentic” on a slide deck and calling it transformation. Banks do not need a machine to summarize a policy document while everyone applauds the demo. They need technology that can touch real workflows without...

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 81

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading

Top 5 Most Recently Viewed Articles

Kos Biotechnology Closes Record-Breaking $123M Fund

Updated Category News Views 80

Unprecedented Funding for Life Sciences When you hear about a $123 million fund popping up from nowhere, you stop and take notice. Kos Biotechnology Partners, a name that's bursting onto the scene with a hefty global life sciences fund, isn't messing around. Got their roots sinking into both New York and the ancient soil of Athens—this isn't just some flash-in-the-pan...

Continue Reading
Lyric Advances Battery Technology with Innovative Equipment

Updated Category News Views 149

Lyric's Innovative Contributions in Battery Technology Recently, Lyric successfully shipped its first solid-state battery front-end equipment to a customer, marking a significant milestone in their ongoing advancements in battery production technology. This achievement is a testament to Lyric's extensive experience and deep expertise in the field of solid-state batteries,...

Continue Reading
Danish Stock Market Update: Modest Decline and Notable Movers

Updated Category News Views 226

Danish Stock Market Sees Modest Decline The recent trading session in Denmark concluded with a slight downturn, marking a challenging day for investors as the OMX Copenhagen 20 index closed lower. The end of trading saw the index experiencing a reduction of 0.23%, setting a new six-month low. Such fluctuations can often reflect broader economic sentiments and provide...

Continue Reading
LiTHOS Group Advances Lithium Extraction with New Patent

Updated Category News Views 275

LiTHOS Group Innovates Lithium Extraction Techniques LiTHOS Group Ltd. (CBOE CA: LITS), a leader in sustainable lithium brine extraction, has achieved a significant milestone by securing a U.S. patent. The United States Patent and Trademark Office (USPTO) has allowed their patent for the "Electro-Pressure Membrane Method for Recovery and Concentration of Lithium from...

Continue Reading
Karbach Brewing: Your Ideal Venue for Memorable Celebrations

Updated Category News Views 378

Karbach Brewing: A New Venue for Unforgettable Corporate Events As the festive season approaches, businesses in Houston are searching for the ideal place to host their corporate holiday celebrations. Enter Karbach Brewing, a name that is rapidly becoming synonymous with memorable experiences. This brewery is not just about beer; it offers companies a distinctive setting...

Continue Reading